Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort

BACKGROUND: Despite the introduction of direct-acting antiviral agents for chronic hepatitis C virus (HCV) infection, peginterferon alfa/ribavirin remains relevant in many resource-constrained settings. The non-randomized GUARD-C cohort investigated baseline predictors of safety-related dose reducti...

Descripción completa

Detalles Bibliográficos
Autores principales: Foster, Graham R., Coppola, Carmine, Derbala, Moutaz, Ferenci, Peter, Orlandini, Alessandra, Reddy, K. Rajender, Tallarico, Ludovico, Shiffman, Mitchell L., Ahlers, Silke, Bakalos, Georgios, Hassanein, Tarek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809570/
https://www.ncbi.nlm.nih.gov/pubmed/27018988
http://dx.doi.org/10.1371/journal.pone.0151703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809570/
https://www.ncbi.nlm.nih.gov/pubmed/27018988
http://dx.doi.org/10.1371/journal.pone.0151703

Ejemplares similares